| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | 15.9% | $8.45M | 9.49M | Foundation Fighting Blindness Retinal Degeneration Fund | Apr 30, 2025 | |||
| Nantahala Capital Management, LLC | 9.99% | 0% | $7.5M | $1.86M | 6.25M | +33.1% | Nantahala Capital Management, LLC | Jun 30, 2025 |
| PERCEPTIVE ADVISORS LLC | 9.99% | $4.01M | 4.51M | Perceptive Advisors LLC | Mar 24, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 19M | $31.9M | +$2.77M | $1.65 | 47 |
| 2025 Q2 | 17.5M | $16.5M | +$2.74M | $0.94 | 43 |
| 2025 Q1 | 14.6M | $14.7M | +$11M | $0.98 | 46 |
| 2024 Q4 | 3.68M | $4.38M | +$107K | $1.19 | 42 |
| 2024 Q3 | 2.53M | $3.32M | -$284K | $1.31 | 37 |
| 2024 Q2 | 2.7M | $4.13M | -$1.25M | $1.53 | 37 |
| 2024 Q1 | 3.37M | $6.78M | -$879K | $2.01 | 48 |
| 2023 Q4 | 3.7M | $11.1M | -$258K | $3.01 | 47 |
| 2023 Q3 | 3.77M | $12.6M | -$57.1K | $3.35 | 51 |
| 2023 Q2 | 3.68M | $16M | +$1M | $4.34 | 53 |
| 2023 Q1 | 3.46M | $13M | +$1.46M | $3.75 | 40 |
| 2022 Q4 | 3.1M | $10.9M | +$1.24M | $3.53 | 34 |
| 2022 Q3 | 2.83M | $5.69M | +$829K | $2.01 | 34 |
| 2022 Q2 | 2.41M | $4.62M | +$369K | $1.92 | 34 |
| 2022 Q1 | 2.05M | $6.62M | -$413K | $3.23 | 34 |
| 2021 Q4 | 2.17M | $8.07M | +$1.42M | $3.73 | 32 |
| 2021 Q3 | 1.68M | $8.62M | +$3.12M | $5.15 | 26 |
| 2021 Q2 | 1.07M | $5.61M | +$364K | $5.27 | 29 |
| 2021 Q1 | 912K | $5.27M | -$7.64M | $5.81 | 21 |
| 2020 Q4 | 2.18M | $14.1M | +$722K | $6.51 | 8 |